Meniere Disease Clinical Trial
— HYDROPSOfficial title:
Evaluation of Inner Ear and Brain Structures With Contrast-enhanced MRI in Healthy Subjects (HYDROPS)
Verified date | November 2020 |
Source | University Hospital, Grenoble |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
- This prospective study aims to better characterize inner ear's perilymphatic structures with Magnetic Resonance Imaging using contrast media and delayed injection in healthy subjects - MR Perfusion Imaging will be assess in both cochlea as well - Primary auditory brain pathways will be evaluated through MR diffusion imaging
Status | Terminated |
Enrollment | 25 |
Est. completion date | September 2020 |
Est. primary completion date | September 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 40 Years and older |
Eligibility | Inclusion Criteria: - Major subjects of over 40 years (mean age of Meniere's disease 40 to 50 years) - Informed consent signed - Medical examination performed prior to participation in research - Patients without history of inner ear disease - Recipient of a French social security scheme Exclusion Criteria: - Patients minors - Patients on a legal protection regime type guardianship - Respiratory pathologies, cardiovascular, renal, diabetes - Claustrophobia - Contraindications to exposure to a magnetic field - Contraindications to injecting Dotarem ® |
Country | Name | City | State |
---|---|---|---|
France | GrenobleUniversityHospital | Grenoble | |
France | Hôpital Lariboisière | Paris | |
France | Hôpital Charles Nicolle | Rouen |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Gadolinium enhancement in inner ear structures as measured by MR T1 Weighted Imaging | One MR scan (4 hours) |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04835688 -
Ventilation Tube Insertion for Unilateral Menière's Disease
|
N/A | |
Recruiting |
NCT05851508 -
The Effecttiveness of Intratympanic Methylprednisolon Injections Compared to Placebo in the Treatment of Vertigo Attacks in Meniere's Disease
|
Phase 3 | |
Not yet recruiting |
NCT05322538 -
Menier's Disease - Bone Density Study
|
N/A | |
Completed |
NCT05328895 -
Transcutaneous Auricular Vagus Nerve Stimulation for Meniere Disease
|
N/A | |
Completed |
NCT04569175 -
Non Enhanced Labyrinth Imaging for the Detection of Endolymphatic Hydrops in Meniere's Disease "NELI Study"
|
N/A | |
Not yet recruiting |
NCT05582148 -
Meniere Disease and Hearing Aids
|
N/A | |
Completed |
NCT05844657 -
Comprehensive Evaluation in Patients With Meniere's Disease
|
||
Completed |
NCT04902963 -
What is the Tympanic Membrane Healing Time After Insertion of a Gelfoam PE Tube?
|
N/A | |
Completed |
NCT04686695 -
Transcutaneous Auricular Vagus Nerve Stimulation Treatment on Meniere Disease
|
N/A | |
Recruiting |
NCT04815187 -
Repurposed Use of Allergic Rhinitis and Allergic Asthma Drug to Reduce Vertigo and Hearing Loss in Meniere's Disease
|
Phase 4 | |
Recruiting |
NCT06278129 -
Evaluation of the Diagnostic and Prognostic Efficacy of MRI in Acute Sensorineural Hearing Loss and Ménière's Disease
|
||
Recruiting |
NCT04766853 -
Verification of the Efficacy/Safety of the Intratympanic Drug Delivery for Hearing Loss
|
Phase 1/Phase 2 | |
Recruiting |
NCT04370366 -
Imaging of Endolymphatic Hydrops at 7T MRI
|
||
Enrolling by invitation |
NCT03520322 -
A Study of a Mastoid Device in Subjects With Ménière's Disease
|
N/A | |
Withdrawn |
NCT04674735 -
Safety of APSLXR in Patients Presenting Vertigo of Vestibular Origin or Meniere's Disease
|
Phase 1 | |
Not yet recruiting |
NCT05424302 -
Effect of Peripheral Vestibular Disease Location on Outcomes Following Home-based Virtual Reality Vestibular Therapy
|
N/A | |
Recruiting |
NCT03795675 -
CI Following VS Removal or Labyrinthectomy
|
N/A | |
Completed |
NCT04218123 -
Assessing the Efficacy of a Serotonin and Norepinephrine Reuptake Inhibitor for Improving Meniere's Disease Outcomes
|
Phase 2/Phase 3 | |
Withdrawn |
NCT02371798 -
Unilateral Meniere Disease: Can Double Dose Gadolinium and Delayed Imaging Make the Diagnosis?
|
N/A | |
Completed |
NCT05960786 -
Treating the Symptoms of Vertigo in a Real-world Setting Using the OtoBand
|
N/A |